Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
D A Fitzmaurice a Department of Primary Care and General
Practice, Medical School, University of Birmingham, Birmingham B15
2TT, b Department
of Haematology, University College London Hospital, London WC1E
6DB Correspondence to: D
A Fitzmaurice d.a.fitzmaurice@bham.ac.uk
| The first 150 words of the full text of this article appear below. |
This paper aims
to provide guidance for clinicians, based on the evidence available
regarding the clinical effectiveness and health economics of the self
management of oral anticoagulation therapy by patients. The paper
focuses on self management, in which patients measure their own
international normalised ratio and interpret the result themselves, as
opposed to self testing, in which patients measure their own
international normalised ratio but have to contact a health
professional for interpretation of the results. The need to provide
guidance and recommendations has been driven by patients' demand for
self management at primary and secondary care levels. This demand has
been fuelled partly by a national media advertising campaign promoting
self management by patients using a particular near patient device
(CoaguChek, Roche Diagnostics, Mannheim) to test their international
normalised ratios. This paper follows on from evidence based guidelines
for the therapeutic management of warfarin that were published by the
Read all Rapid Responses